Free File | Jotup

IRS Free File Now Open for 2024 - The Free File Alliance Offers Taxpayers Free Industry-Leading Tax Software

Retrieved on:

Friday, January 12, 2024

Free File, Identity theft, AGI, Tax, Android, Free File Alliance, Security awareness, Security, Software, TaxSlayer, Tablet, IRS, Free, Internal Revenue Service, Average revenue per user, IOS, English, Online shopping

WASHINGTON, Jan. 12, 2024 /PRNewswire/ -- Taxpayers can get a head start on preparing their tax returns as Free federal tax preparation and e-filing software is now available at www.IRS.gov/FreeFile to all Americans with a 2023 adjusted gross income (AGI) of $79,000 or less. Powered by The Free File Alliance, a coalition of 8 industry-leading tax software companies partnered with the Internal Revenue Service (IRS), the Free File program gives eligible taxpayers free access to the industry's most innovative and secure tax software in order to easily prepare and e-file their federal tax returns. In many instances, taxpayers will also have the option of simultaneously filing their state income tax return for free, as well.

Key Points:

Powered by The Free File Alliance , a coalition of 8 industry-leading tax software companies partnered with the Internal Revenue Service (IRS), the Free File program gives eligible taxpayers free access to the industry's most innovative and secure tax software in order to easily prepare and e-file their federal tax returns.
Free File members for tax season 2024 are: 1040Now, Inc.; 1040.com (Drake) ezTaxReturn.com (English and Spanish); FileYourTaxes.com; On-Line Taxes, Inc.; TaxAct; TaxHawk (FreeTaxUSA); and TaxSlayer.
With the tax filing season not officially opening until January 29th, eligible taxpayers can get a head start on their taxes by e-filing utilizing the Free File software.
Taxpayers can also use their smart phones or tablets to electronically prepare and file their federal and state tax returns through IRS Free File.

Fortress Biotech Announces Closing of $10.0 Million Public Offering

Retrieved on:

Tuesday, November 14, 2023

Sale, Fortress Biotech, Research, Roth Capital Partners, Security (finance), S-3, Form, Free File, Prospectus, Fortification

The warrants are immediately exercisable at a price of $1.70 per share and expire five years from the date of issuance.

Key Points:

The warrants are immediately exercisable at a price of $1.70 per share and expire five years from the date of issuance.
Certain directors and officers of the Company participated in the offering and purchased an aggregate amount of approximately $2.9 million of units at the same purchase price.
The gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses, are approximately $10.0 million.
The offering was made only by means of a prospectus supplement which is a part of the effective registration statement.

Golden Minerals Announces Closing of US$4.2 Million Public Offering

Retrieved on:

Wednesday, November 8, 2023

Mining, Minerals, Natural Resources, Sale, Free File, Security (finance), United Western Minerals Company, Park Avenue, NYSE, Form, Exercise, 3rd Floor, Prospectus, Series, TSX, Golden

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

Key Points:

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
The gross proceeds from the offering were approximately $4.2 million, prior to deducting placement agent’s fees and other offering expenses payable by Golden.
Golden intends to use the net proceeds from the offering for working capital and other general corporate purposes.
The offering of the securities described above was made only by means of a prospectus forming part of the effective registration statement relating to the offering.

Avenue Therapeutics Announces Closing of $5.0 Million Public Offering

Retrieved on:

Thursday, November 2, 2023

Suite, Sale, Free File, Security (finance), Park Avenue, Form, Prospectus, DSM-IV codes, ATTN:, Therapy, Financial adviser

MIAMI, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced the closing of its previously announced public offering of an aggregate of 16,633,400 units (or pre-funded units in lieu thereof) at a public offering price of $0.3006 per unit (inclusive of the pre-funded warrant exercise price of $0.0001 per share).

Key Points:

MIAMI, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced the closing of its previously announced public offering of an aggregate of 16,633,400 units (or pre-funded units in lieu thereof) at a public offering price of $0.3006 per unit (inclusive of the pre-funded warrant exercise price of $0.0001 per share).
The gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses, are approximately $5.0 million.
Maxim Group LLC and Lake Street Capital Markets, LLC acted as placement agents for the offering.
The offering was made only by means of a prospectus which is a part of the effective registration statement.

Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering

Retrieved on:

Tuesday, October 31, 2023

Suite, Sale, Free File, Security (finance), Park Avenue, Form S-1, Form, Prospectus, DSM-IV codes, ATTN:, Therapy

MIAMI, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced the pricing of its public offering of an aggregate of 16,633,400 units at a public offering price of $0.3006 per unit.

Key Points:

MIAMI, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced the pricing of its public offering of an aggregate of 16,633,400 units at a public offering price of $0.3006 per unit.
The gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses, are expected to be approximately $5.0 million.
Maxim Group LLC and Lake Street Capital Markets, LLC are acting as placement agents for the offering.
The offering is being made only by means of a prospectus which is a part of the effective registration statement.

SELLAS Life Sciences Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Retrieved on:

Tuesday, October 31, 2023

SLS, Sale, Free File, Telephone, Form, Madison Avenue, S-3, Security (finance)

The Company further agreed to issue to the investor warrants to purchase up to an aggregate of 3,652,300 shares of common stock.

Key Points:

The Company further agreed to issue to the investor warrants to purchase up to an aggregate of 3,652,300 shares of common stock.
The warrants will have an exercise price of $0.9702, will be immediately exercisable and will expire five years after issuance.
The closing of the offering is expected to occur on or about November 2, 2023, subject to the satisfaction of customary closing conditions.
A.G.P./Alliance Global Partners is acting as the lead placement agent for the offering and Maxim Group LLC is acting as a co-placement agent for the offering.

Golden Minerals Announces US$4.2 Million Public Offering

Retrieved on:

Monday, November 6, 2023

Mining, Minerals, Natural Resources, Sale, Free File, Security (finance), United Western Minerals Company, Park Avenue, NYSE, Form, Exercise, 3rd Floor, Prospectus, Series, TSX, Golden

Golden Minerals Company (“Golden Minerals”, “Golden” or the “Company”) (NYSE American: AUMN and TSX: AUMN) is pleased to announce the pricing of its public offering of an aggregate of 6,000,000 shares of its common stock (or common stock equivalents in lieu thereof), Series A warrants to purchase up to 6,000,000 shares of common stock and Series B warrants to purchase up to 3,000,000 shares of common stock, at a public offering price of $0.70 per share of common stock (or common stock equivalent in lieu thereof) and accompanying warrants.

Key Points:

Golden Minerals Company (“Golden Minerals”, “Golden” or the “Company”) (NYSE American: AUMN and TSX: AUMN) is pleased to announce the pricing of its public offering of an aggregate of 6,000,000 shares of its common stock (or common stock equivalents in lieu thereof), Series A warrants to purchase up to 6,000,000 shares of common stock and Series B warrants to purchase up to 3,000,000 shares of common stock, at a public offering price of $0.70 per share of common stock (or common stock equivalent in lieu thereof) and accompanying warrants.
The offering is expected to close on or about November 8, 2023, subject to the satisfaction of customary closing conditions.
The gross proceeds from the offering are expected to be approximately $4.2 million, prior to deducting placement agent’s fees and other offering expenses payable by Golden.
Golden intends to use the net proceeds from the offering for working capital and other general corporate purposes.

ATEC Announces Closing of Public Stock Offering

Retrieved on:

Friday, October 27, 2023

Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the closing of its previously announced underwritten public offering of 14,300,000 shares of its common stock at a public offering price of $10.50 per share.

Key Points:

Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the closing of its previously announced underwritten public offering of 14,300,000 shares of its common stock at a public offering price of $10.50 per share.
Morgan Stanley, TD Cowen, Barclays and Stifel acted as joint book-running managers in the offering.
ATEC received gross proceeds from the offering of $150,150,000.
The shares of common stock were offered pursuant to a shelf registration statement on Form S-3 (File No.

Northann Corp. Announces Closing of $6,000,000 Initial Public Offering

Retrieved on:

Monday, October 23, 2023

Sale, Free File, NYSE, Form, Acquisition, Offering, Prospectus, Marketing, NYSE American, NCL, Security (finance)

Elk Grove, CA, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Northann Corp. (“Northann” or the “Company”) (NYSE American: NCL), a company specializing in 3D-printed flooring solutions, today announced the closing of its previously announced initial public offering of 1,200,000 shares of common stock priced at $5 per share, for total gross proceeds of $6,000,000, before deducting underwriting discounts and other offering expenses (the “Offering”).

Key Points:

Elk Grove, CA, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Northann Corp. (“Northann” or the “Company”) (NYSE American: NCL), a company specializing in 3D-printed flooring solutions, today announced the closing of its previously announced initial public offering of 1,200,000 shares of common stock priced at $5 per share, for total gross proceeds of $6,000,000, before deducting underwriting discounts and other offering expenses (the “Offering”).
The Offering closed on October 23, 2023.
The Offering is being conducted on a firm commitment basis.
Lafferty & Co., Inc. are acting as co-underwriters for the Offering.

Nxu, Inc. Announces $3.0 Million Public Offering of Common Stock

Retrieved on:

Thursday, October 19, 2023

Sale, Free File, Security (finance), Park Avenue, EV, Telephone, Form, Attention, Prospectus

The gross proceeds of the offering to the Company, before deducting placement agent fees and commissions and other offering expenses, are expected to be approximately $3.0 million.

Key Points:

The gross proceeds of the offering to the Company, before deducting placement agent fees and commissions and other offering expenses, are expected to be approximately $3.0 million.
The offering is expected to close on or about October 23, 2023, subject to customary closing conditions.
Maxim Group LLC is acting as the sole placement agent in connection with the offering.
The offering is being conducted pursuant to the Company’s registration statement on Form S-1, as amended, (File No.